AdaptHealth CCO sells 11,275 shares under plan

AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III reported an open-market sale of 11,275 shares of Common Stock on July 1, 2026 at $10.44 per share.

Rhea-AI Filing Summary

AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III reported an open-market sale of 11,275 shares of Common Stock on July 1, 2026 at $10.44 per share. The filing shows he now directly holds 125,263 shares after the transaction.

The sale occurred automatically under a Rule 10b5-1 trading plan that Schuster adopted on March 2, 2026, indicating the trade was pre-scheduled rather than a discretionary market-timing decision.

Insider Trade Summary 10b5-1

Net Seller: 11,275 shares

Net Sell 1 txn

Insider Schuster III Russell E.

Role Chief Commercial Officer

Sold 11,275 shs ($118K)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,275	$10.44	$118K

Holdings After Transaction: Common Stock — 125,263 shares (Direct)

Footnotes (1)

1. F1. The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

Key Figures

Shares sold: 11,275 shares Sale price: $10.44 per share Shares owned after transaction: 125,263 shares +1 more

4 metrics

Shares sold 11,275 shares Open-market sale of Common Stock on July 1, 2026

Sale price $10.44 per share Price for the 11,275 shares sold

Shares owned after transaction 125,263 shares Direct holdings of Russell E. Schuster III after sale

Net shares sold 11,275 shares Net-sell direction per transaction summary

Key Terms

Rule 10b5-1 trading plan, open-market sale, Common Stock, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: "open-market sale" for 11,275 shares of Common Stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock" in the Form 4 transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"The sale reported in this Form 4 occurred automatically"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) report for Russell E. Schuster III?

AdaptHealth reported that Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of Common Stock. The sale was executed as an open-market transaction at $10.44 per share and was carried out under a pre-established Rule 10b5-1 trading plan.

At what price did the AdaptHealth (AHCO) insider shares trade in this Form 4?

The reported AdaptHealth insider sale was executed at $10.44 per share. Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of Common Stock at this price in an open-market transaction disclosed in the Form 4 filing.

How many AdaptHealth (AHCO) shares does Russell E. Schuster III hold after the sale?

Following the reported transaction, Russell E. Schuster III directly holds 125,263 shares of AdaptHealth Common Stock. This post-transaction balance is disclosed in the Form 4 and reflects his remaining direct ownership after selling 11,275 shares.

Was the AdaptHealth (AHCO) insider sale made under a Rule 10b5-1 plan?

Yes. The Form 4 states the sale occurred automatically under a Rule 10b5-1 trading plan. The plan was adopted by Russell E. Schuster III on March 2, 2026, indicating the trade was pre-scheduled rather than a discretionary decision based on short-term market conditions.

What role does Russell E. Schuster III hold at AdaptHealth (AHCO)?

Russell E. Schuster III serves as Chief Commercial Officer of AdaptHealth. His position is identified in the Form 4 filing, which reports his open-market sale of 11,275 shares of AdaptHealth Common Stock and his remaining direct ownership stake after the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schuster III Russell E.

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S(1)		11,275	D	$10.44	125,263	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2026.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on February 4, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Russell Schuster	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)